ZOETIS INC (ZTS) Stock Overview
NYSE:ZTS - US98978V1035 - Common Stock
ZTS Key Statistics, Chart & Performance
The current stock price of ZTS is 155.57 USD. In the past month the price increased by 2.95%. In the past year, price decreased by -15.42%.
ZTS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 44.89 | 686.18B | ||
| JNJ | JOHNSON & JOHNSON | 17.68 | 425.75B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.05 | 248.53B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.28 | 244.73B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 14.06 | 244.32B | ||
| MRK | MERCK & CO. INC. | 11.07 | 212.90B | ||
| PFE | PFIZER INC | 7.38 | 142.20B | ||
| SNY | SANOFI-ADR | 11.3 | 122.36B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 7.02 | 96.19B | ||
| GSK | GSK PLC-SPON ADR | 8.79 | 80.26B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 49.55 | 46.95B | ||
| HLN | HALEON PLC-ADR | 19.62 | 43.14B |
Related stock screener links
About ZTS
Company Profile
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The company is headquartered in Parsippany, New Jersey and currently employs 13,800 full-time employees. The company went IPO on 2013-02-01. The firm is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The firm operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. The company directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The firm is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
Company Info
ZOETIS INC
10 Sylvan Way
Parsippany NEW JERSEY 07054 US
CEO: Kristin C. Peck
Employees: 13800
Phone: 19738227000
ZOETIS INC / ZTS FAQ
What is the stock price of ZOETIS INC today?
The current stock price of ZTS is 155.57 USD. The price increased by 0.24% in the last trading session.
What is the ticker symbol for ZOETIS INC stock?
The exchange symbol of ZOETIS INC is ZTS and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is ZTS stock listed?
ZTS stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for ZOETIS INC stock?
24 analysts have analysed ZTS and the average price target is 195.62 USD. This implies a price increase of 25.75% is expected in the next year compared to the current price of 155.57. Check the ZOETIS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ZOETIS INC worth?
ZOETIS INC (ZTS) has a market capitalization of 68.95B USD. This makes ZTS a Large Cap stock.
How many employees does ZOETIS INC have?
ZOETIS INC (ZTS) currently has 13800 employees.
What are the support and resistance levels for ZOETIS INC (ZTS) stock?
ZOETIS INC (ZTS) has a support level at 155.01 and a resistance level at 156.01. Check the full technical report for a detailed analysis of ZTS support and resistance levels.
Is ZOETIS INC (ZTS) expected to grow?
The Revenue of ZOETIS INC (ZTS) is expected to grow by 2.92% in the next year. Check the estimates tab for more information on the ZTS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ZOETIS INC (ZTS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ZTS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ZTS, evaluating the profitability, health, valuation and growth aspects
- ZOETIS INC (ZTS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ZOETIS INC (ZTS) Sales and EPS estimates to see what analysts future expectations are.
- ZOETIS INC (ZTS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ZOETIS INC (ZTS) Insider and Institutional Ownership to learn about the owners and their transactions.
- ZOETIS INC (ZTS) Stock Chart to make your own analysis
- ZOETIS INC (ZTS) Latest news and press-releases to stay up to date.
Does ZOETIS INC (ZTS) stock pay dividends?
ZOETIS INC (ZTS) has a dividend yield of 1.31%. The yearly dividend amount is currently 1.73. Check the full fundamental report for a detailed analysis of ZTS dividend history, reliability and sustainability.
When does ZOETIS INC (ZTS) report earnings?
ZOETIS INC (ZTS) will report earnings on 2025-11-03, before the market open.
What is the Price/Earnings (PE) ratio of ZOETIS INC (ZTS)?
The PE ratio for ZOETIS INC (ZTS) is 25.01. This is based on the reported non-GAAP earnings per share of 6.22 and the current share price of 155.57 USD. Check the full fundamental report for a full analysis of the valuation metrics for ZTS.
What is the Short Interest ratio of ZOETIS INC (ZTS) stock?
The outstanding short interest for ZOETIS INC (ZTS) is 1.55% of its float. Check the ownership tab for more information on the ZTS short interest.
ZTS Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to ZTS. When comparing the yearly performance of all stocks, ZTS is a bad performer in the overall market: 84.98% of all stocks are doing better.
ZTS Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to ZTS. While ZTS belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
ZTS Financial Highlights
Over the last trailing twelve months ZTS reported a non-GAAP Earnings per Share(EPS) of 6.22. The EPS increased by 12.27% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 27.83% | ||
| ROA | 18.04% | ||
| ROE | 52.48% | ||
| Debt/Equity | 1.05 |
ZTS Forecast & Estimates
24 analysts have analysed ZTS and the average price target is 195.62 USD. This implies a price increase of 25.75% is expected in the next year compared to the current price of 155.57.
For the next year, analysts expect an EPS growth of 8.32% and a revenue growth 2.92% for ZTS